Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis.
Andrew R KolodziejMohamed Abo-AlyEman ElsawalhyCharles CampbellKhaled M ZiadaAhmed Abdel-LatifPublished in: Mediators of inflammation (2019)
Our meta-analysis suggests that high MPO levels are associated with the risk of mortality and that MPO can be incorporated in risk stratification models that guide therapy of high-risk ACS patients.
Keyphrases
- systematic review
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- acute coronary syndrome
- prognostic factors
- cardiovascular events
- randomized controlled trial
- cardiovascular disease
- risk factors
- type diabetes
- stem cells
- coronary artery disease
- mesenchymal stem cells
- meta analyses
- patient reported outcomes